Ibrutinib Therapy and Mycobacterium chelonae Skin and Soft Tissue Infection

被引：13

作者：

Dousa, Khalid M. ^{[1
]}

Babiker, Ahmed ^{[2
]}

Van Aartsen, Daniel ^{[1
]}

Shah, Neel ^{[2
]}

Bonomo, Robert A. ^{[3
,4
,5
,6
,7
,8
,9
]}

Johnson, John L. ^{[1
]}

Skalweit, Marion J. ^{[3
]}

机构：

[1] Univ Hosp Cleveland, Med Ctr, Div Infect Dis & HIV Med, Foley Bldg,Room 416,11100 Euclid Ave, Cleveland, OH 44106 USA

[2] Univ Pittsburgh, Med Ctr, Div Infect Dis, Pittsburgh, OH USA

[3] Vet Affairs Med Ctr, Louis Stokes Cleveland Dept, Infect Dis Sect, Cleveland, OH USA

[4] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA

[5] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA

[6] Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA

[7] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA

[8] Case Western Reserve Univ, Sch Med, Dept Prote & Bioinformat, Cleveland, OH 44106 USA

[9] CWRU Cleveland VAMC Ctr Antimicrobial Resistance, Cleveland, OH USA

来源：

OPEN FORUM INFECTIOUS DISEASES | 2018年 / 5卷 / 07期

关键词：

chronic lymphocytic leukemia; ibrutinib; Mycobacterium chelonae; nontuberculous mycobacteria; skin and soft tissue infection; KINASE INHIBITORS;

D O I：

10.1093/ofid/ofy168

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Ibrutinib is an irreversible inhibitor of Bruton's tyrosine kinase approved for the treatment of B-cell malignancies. There is growing concern about the risk of opportunistic infections following ibrutinib therapy. Herein, we describe the first case of Mycobacterium chelonae skin and soft tissue infection in a patient receiving ibrutinib and recount the challenges in treating this infection.

引用

页数：3

共 50 条

[1] Mycobacterium chelonae - a growing problem in soft tissue infection
Hay, Rod J.
CURRENT OPINION IN INFECTIOUS DISEASES, 2009, 22 (02) : 99 - 101
[2] Mycobacterium chelonae soft-tissue infection in an immunocompetent child
Bosman, Alexis G.
Beer, Jason
Grimwood, Keith
JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2023, 59 (02) : 401 - 403
[3] A Report of Two Uncommon Cases of Mycobacterium chelonae with Localized and Disseminated Skin and Soft Tissue Infection
Prada, Libardo Rueda
Gorasevic, Marko
Gavrancic, Tatjana
Rajani, Aayushi J.
Sluzevich, Jason C.
Nair-Collins, Sangeeta
Durvasula, Ravi V.
INFECTIOUS DISEASE REPORTS, 2025, 17 (01)
[4] THE TURTLES REVENGE - A CASE OF SOFT-TISSUE MYCOBACTERIUM-CHELONAE INFECTION
MILLER, AC
COMMENS, CA
JAWORSKI, R
PACKHAM, D
MEDICAL JOURNAL OF AUSTRALIA, 1990, 153 (08) : 493 - 495
[5] Skin and Soft Tissue Infections Caused by Mycobacterium chelonae: More Common Than Expected?
Uslu, Ugur
Boehm, Olga
Heppt, Franz
Sticherling, Michael
ACTA DERMATO-VENEREOLOGICA, 2019, 99 (10) : 889 - 893
[6] Mycobacterium chelonae infection associated with adalimumab therapy
Diaz, F.
Urkijo, J. C.
Mendoza, F.
de la Viuda, J. M.
Blanco, M.
Unzurrunzaga, A.
Ayarza, R.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2008, 37 (02) : 159 - 160
[7] Simultaneous skin infection of Mycobacterium chelonae and Nocardia thailandica
Morimoto, Kenta
Iwamoto, Yutaro
Kanazawa, Azusa
Okiyama, Naoko
JOURNAL OF DERMATOLOGY, 2025, 52 (02): : e184 - e185
[8] Mycobacterium chelonae skin infection in kidney pancreas recipient
Stelzmueller, I
Dunst, KM
Wiesmayr, S
Zangerle, R
Hengster, P
Bonatti, H
EMERGING INFECTIOUS DISEASES, 2005, 11 (02) : 352 - 354
[9] Mycobacterium chelonae resistant to therapy as a Cause of Skin Ulcers
Dippel, O.
Herbst, C.
Harrer, T.
Sticherling, M.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 107 - 107
[10] Mycobacterium neoaurum as an unusual cause of skin and soft tissue infection
Chadha, Mehak
Arias, Mauricio
Maxwell-Scott, Hector
Creamer, Daniel
Boissiere, Jeanne
Sioletic, Stefano
Lampejo, Temi
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2023, 62 (01) : E45 - E47

← 1 2 3 4 5 →